Key facts
- ReferWell’s last known valuation is $37.9M (Aug 2025).
- It has raised $17.1M; the latest was Later Stage VC ($7.9M) in Aug 2025.
- Notable investors include Connecticut Innovations, New York Angels, Viewside Capital Partners, Zeal Tech, Blueprint Health — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for ReferWell
- ·The full record, as it builds
Funding rounds
No funding rounds for ReferWell are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ReferWell
Developer of a cloud-based platform designed to solve the last-mile problem of healthcare. The company manages all aspects of scheduling the care transition to close care gaps, enabling the healthcare providers and networks to gain increased revenues and lower costs while patients get an improved experience and healthier outcomes.
- Sector
- Healthcare
- HQ
- Stamford, CT, United States
- Founded
- 2014
- Employees
- 55
- Website
- engage.referwell.com/
- Ownership
- Privately Held (backing)
ReferWell doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ReferWell shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ReferWell in its N-PORT filings yet. We sweep new filings monthly.